explore -WSS

explore

author：Wikipedia 2025-09-29 19:07:22 - browse：545

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Gritstone Bio's cancer vaccine test, and more on Novartis' deal

WSS

Adopting new red light myopia treatments may be short

Readout LOUD: Venture capital, Gilead, and more M&A

Pharma patents targeted by Biden in move to slash drug prices

The woman behind the Dana Farber

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

The Biogen Aduhelm mess could happen again

knowledge

explore

explore

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: Amgen, Regeneron, BGI Group and more

At least 13 dead in Texas as scorching temps continue

Chemotherapy shortages won’t get better under Biden’s latest plan

Cancer drug shortages should be causing more outrage

Why sickle cell disease is getting the first CRISPR treatment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Supreme Court wrestles with OxyContin maker's bankruptcy deal

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Johnson & Johnson sued for allegedly overpaying for workers' drugs

entertainment

Readout LOUD: Venture capital, Gilead, and more M&A

SCOTUS to consider access to abortion pill mifepristone

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Americans' trust in science, scientist continues decline: Report

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

focus

explore

entertainment

focus